John Gordon

Title: The Innovations of John Gordon

Introduction

John Gordon is a notable inventor based in Wilmington, DE (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of radioactive compounds. His work has implications for treating various diseases and conditions.

Latest Patents

John Gordon holds 1 patent for his invention titled "Ligands." This patent describes a radioactive compound with a specific formula and pharmaceutically-acceptable salts. The invention includes enantiomers, in vivo-hydrolysable precursors, and pharmaceutical compositions. It also outlines methods for using these compounds to treat diseases, either alone or in combination with other therapeutically-active substances. Additionally, the patent details processes and intermediates used to prepare these compounds, as well as their uses for diagnostic and analytic purposes.

Career Highlights

John Gordon is currently employed at AstraZeneca AB, a leading global biopharmaceutical company. His work at AstraZeneca focuses on innovative solutions in the pharmaceutical industry, contributing to advancements in medical treatments.

Collaborations

Throughout his career, John has collaborated with notable colleagues, including Peter Dorff and Dennis J McCarthy. These collaborations have further enhanced his research and development efforts in the pharmaceutical field.

Conclusion

John Gordon's innovative work in the development of radioactive compounds showcases his commitment to advancing medical science. His contributions have the potential to significantly impact the treatment of various diseases and conditions.